NBTK.DE vs. GLD
NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) and GLD (SPDR Gold Shares) are both exchange-traded funds - NBTK.DE is a Health & Biotech Equities fund tracking the Nasdaq Biotechnology, while GLD is a Gold fund tracking the LBMA Gold Price PM. Both are passively managed. Over the past 5 years, NBTK.DE returned 5.63%/yr vs 19.45%/yr for GLD. At a 0.05 correlation, their price movements are largely independent. Both charge a 0.40% expense ratio.
Performance
NBTK.DE vs. GLD - Performance Comparison
Loading charts...
Different Trading Currencies
NBTK.DE is traded in EUR, while GLD is traded in USD. To make them comparable, the GLD values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly lower than GLD's 4.96% return.
NBTK.DE
- 1D
- 2.92%
- 1M
- 0.38%
- YTD
- 4.27%
- 6M
- 3.76%
- 1Y
- 39.20%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
GLD
- 1D
- 0.00%
- 1M
- -3.47%
- YTD
- 4.96%
- 6M
- 6.67%
- 1Y
- 31.01%
- 3Y*
- 27.58%
- 5Y*
- 19.45%
- 10Y*
- 12.97%
NBTK.DE vs. GLD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
GLD SPDR Gold Shares | 1.94% | 44.25% | 35.02% | 9.31% | 5.38% | 3.02% | 14.53% | 1.69% |
Correlation
The correlation between NBTK.DE and GLD is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 0.05 |
The correlation between NBTK.DE and GLD shifts across timeframes, from 0.05 (all time) to 0.15 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBTK.DE vs. GLD — Risk / Return Rank
NBTK.DE
GLD
NBTK.DE vs. GLD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and SPDR Gold Shares (GLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NBTK.DE | GLD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.79 | ||
| Sortino ratioReturn per unit of downside risk | +1.22 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.25 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 6.16 | 1.82 | +4.34 |
| Martin ratioReturn relative to average drawdown | 17.06 | 4.30 | +12.76 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NBTK.DE | GLD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.03 | 1.24 | +0.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 1.17 | -0.90 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.87 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.65 | -0.24 |
Drawdowns
NBTK.DE vs. GLD - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum GLD drawdown of -37.47%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and GLD.
Loading charts...
Drawdown Indicators
| NBTK.DE | GLD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.99% | -37.47% | +6.48% |
Max Drawdown (1Y)Largest decline over 1 year | -6.24% | -17.14% | +10.90% |
Max Drawdown (3Y)Largest decline over 3 years | -29.35% | -17.14% | -12.21% |
Max Drawdown (5Y)Largest decline over 5 years | -30.99% | -17.14% | -13.85% |
Max Drawdown (10Y)Largest decline over 10 years | — | -18.63% | — |
Current DrawdownCurrent decline from peak | -1.44% | -15.52% | +14.08% |
Average DrawdownAverage peak-to-trough decline | -10.62% | -12.17% | +1.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.26% | 7.23% | -4.97% |
Volatility
NBTK.DE vs. GLD - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) has a higher volatility of 6.41% compared to SPDR Gold Shares (GLD) at 3.75%. This indicates that NBTK.DE's price experiences larger fluctuations and is considered to be riskier than GLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBTK.DE | GLD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.41% | 3.75% | +2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 21.79% | -7.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.00% | 25.17% | -6.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.30% | 16.69% | +3.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.05% | 14.91% | +7.14% |
NBTK.DE vs. GLD - Expense Ratio Comparison
Both NBTK.DE and GLD have an expense ratio of 0.40%.
Dividends
NBTK.DE vs. GLD - Dividend Comparison
Neither NBTK.DE nor GLD has paid dividends to shareholders.
Frequently Asked Questions
NBTK.DE and GLD have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.40% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
NBTK.DE and GLD have the same expense ratio: 0.40% per year.
NBTK.DE is categorized as Health & Biotech Equities, while GLD is Gold. NBTK.DE tracks Nasdaq Biotechnology, while GLD tracks LBMA Gold Price PM. They also come from different issuers: Invesco and State Street.
Find the right allocation for NBTK.DE and GLD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer